BIO - Latest News

Bio-Rad Laboratories, Inc. (BIO), operates in Healthcare / Medical - Devices, trades on NYSE.

Market capitalization stands near $8.13B. Trailing twelve-month P/E ratio is 48.04. Beta to the broader market is 1.08.

The article list below shows the most recent BIO headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent BIO Headlines

Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 6.5% Rally? GF Value Says Undervalued

gurufocus.com - Jun 25, 2026

On June 25, 2026, Bio-Rad Laboratories Inc (BIO) shares rose 6. 5% to $298.

HKSTP Leads Largest-Ever Hong Kong Delegation to BIO 2026 Showcasing Life and Health Tech Strength

thenewswire.com - Jun 24, 2026

41 local tech firms, institutes and university spin-offs head to San Diego to forge global partnerships, reinforcing the city's status as internationa

BIO CEO says more consistency needed in FDA review process

reuters.com - Jun 23, 2026

U. S.

Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026?

fool.com - Jun 22, 2026

Bio-Rad Laboratories offers high profitability and a liquid balance sheet with a current ratio above 5x. Charles River Laboratories International mai

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention

globenewswire.com - Jun 22, 2026

ALAMEDA, Calif. , June 22, 2026 (GLOBE NEWSWIRE) -- Vivani Medical, Inc.

How News Affects BIO Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track BIO's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked BIO news questions

What is the latest BIO news headline?
The most recent BIO headline (Jun 25, 2026) is "Is It Too Late to Buy Bio-Rad Laboratories Inc (BIO) After 6.5% Rally? GF Value Says Undervalued". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the BIO news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What BIO news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual BIO options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.